NovaDel Announces Positive Data from Pilot Pharmacokinetic Study Comparing Tizanidine Oral Spray to Zanaflex Tablets
FLEMINGTON, N.J.--(BUSINESS WIRE)--Apr 7, 2008 - NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced pharmacokinetic (PK), pharmacodynamic... (Source: Drugs.com - Clinical Trials)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div

Blood Cancers: New Data and Novel AgentsBlood Cancers: New Data and Novel Agents
Dr. Bruce Cheson previews studies to be presented at ASCO® 2012 that will change or confirm therapies in follicular lymphoma, Hodgkin lymphoma, myeloma, and more. Medscape Hematology-Oncology (Source: Medscape Today Headlines)